See more : NextGen Healthcare, Inc. (QY1.F) Income Statement Analysis – Financial Results
Complete financial analysis of Adams Diversified Equity Fund, Inc. (ADX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Adams Diversified Equity Fund, Inc., a leading company in the Asset Management industry within the Financial Services sector.
You may be interested
- Telenor ASA (TEL.OL) Income Statement Analysis – Financial Results
- Iron Horse Acquisitions Corp. Right (IROHR) Income Statement Analysis – Financial Results
- Hangzhou Sunrise Technology Co., Ltd. (300360.SZ) Income Statement Analysis – Financial Results
- ACS, Actividades de Construcción y Servicios, S.A. (ACSAY) Income Statement Analysis – Financial Results
- REYON Pharmaceutical Co., Ltd. (102460.KS) Income Statement Analysis – Financial Results
Adams Diversified Equity Fund, Inc. (ADX)
Industry: Asset Management
Sector: Financial Services
Website: https://www.adamsfunds.com/funds/diversified-equity
About Adams Diversified Equity Fund, Inc.
Adams Diversified Equity Fund, Inc. is a publicly owned investment manager. The firm provides its services to investment companies. The firm invests in the public equity markets of the United States. It invests in stocks of large-cap companies across diversified sectors to make its investments. The firm employs a fundamental, technical and quantitative analysis with a bottom-up stock picking approach, while focusing on earnings growth prospects, financial strength, cash flow generation, macro-economics, capital allocation, market competition, profitability. It obtains external research to complement its in-house research to make its investments. The firm benchmarks the performance of its portfolios against the S&P 500 Index. It was formerly known as The Adams Express Company. Adams Diversified Equity Fund, Inc. was founded in 1840 and is based in Baltimore, Maryland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 173.82M | -458.78M | 638.99M | 361.70M | 490.69M | -51.61M | 382.90M | 106.20M | 101.43M | 27.71M | 27.53M | 24.94M | 19.94M | 19.41M | 19.61M | 26.66M | 32.12M | 26.23M | 23.97M | 24.34M | 20.69M | 20.80M | 24.16M | 26.17M | 24.82M | 25.95M | 25.79M | 27.79M |
| Cost of Revenue | 1.52M | 1.53M | 1.51M | 1.36M | 1.25M | 1.16M | 1.09M | 1.07M | 3.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 172.30M | -460.32M | 637.48M | 360.34M | 489.44M | -52.77M | 381.81M | 105.13M | 98.03M | 27.71M | 27.53M | 24.94M | 19.94M | 19.41M | 19.61M | 26.66M | 32.12M | 26.23M | 23.97M | 24.34M | 20.69M | 20.80M | 24.16M | 26.17M | 24.82M | 25.95M | 25.79M | 27.79M |
| Gross Profit Ratio | 99.12% | 100.33% | 99.76% | 99.62% | 99.74% | 102.25% | 99.72% | 98.99% | 96.65% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | -3.40 | 1.83 | 2.81 | 3.00 | -0.29 | 2.58 | 1.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 5.43M | 4.63M | 5.64M | 4.88M | 4.40M | 4.52M | 4.14M | 8.48M | 8.64M | 8.24M | 8.61M | 7.13M | 5.89M | 5.86M | 7.85M | 5.40M | 5.97M | 6.32M | 5.50M | 5.11M | 4.90M | 3.86M | 2.79M | 4.99M | 5.43M | 2.66M | 4.26M | 2.72M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -8.48M | 1.25M | 348.40K | 262.58K | 263.51K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.43M | 4.63M | 5.64M | 4.88M | 4.40M | 4.52M | 4.14M | 1.11 | 9.88M | 8.59M | 8.87M | 7.39M | 5.89M | 5.86M | 7.85M | 5.40M | 5.97M | 6.32M | 5.50M | 5.11M | 4.90M | 3.86M | 2.79M | 4.99M | 5.43M | 2.66M | 4.26M | 2.72M |
| Other Expenses | 0.00 | 7.71M | 8.26M | 6.87M | 7.53M | 5.54M | 5.23M | 99.44M | -81.72M | 77.33K | 30.00K | 340.00K | 790.00K | 10.00K | -3.67M | 4.23M | 430.00K | 220.00K | 180.00K | 230.00K | 180.00K | 200.00K | 280.00K | 240.00K | 250.00K | 710.00K | 740.00K | 830.00K |
| Operating Expenses | 517.78M | 12.34M | 13.90M | 11.75M | 11.94M | 10.06M | 9.37M | 89.33M | 81.72M | 160.84M | 299.28M | 121.16M | 6.68M | 5.87M | 4.18M | 9.63M | 6.40M | 6.54M | 5.68M | 5.34M | 5.08M | 4.06M | 3.07M | 5.23M | 5.68M | 3.37M | 5.00M | 3.55M |
| Cost & Expenses | -379.10M | 12.34M | 13.90M | 11.75M | 11.94M | 10.06M | 9.37M | 105.13M | 85.12M | 160.84M | 299.28M | 121.16M | 6.68M | 5.87M | 4.18M | 9.63M | 6.40M | 6.54M | 5.68M | 5.34M | 5.08M | 4.06M | 3.07M | 5.23M | 5.68M | 3.37M | 5.00M | 3.55M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 413.75K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 97.10M | 168.44M | 308.15M | 128.55M | 0.00 | 95.40M | 225.70M | 0.00 | 52.13M | 158.83M | 26.63M | 116.27M | 236.65M | -285.88M | -508.79M | -123.10M | 526.34M | 296.90M | 314.43M | 171.21M | |
| Depreciation & Amortization | -21.02M | -22.54M | -19.06M | -21.78M | -21.60M | -20.64M | -21.74M | -18.91M | -16.79M | -19.12M | -18.66M | -17.55M | -101.43M | 190.80M | 451.40M | -978.94M | 104.25M | 317.66M | 53.26M | 232.54M | 473.30M | -571.76M | -1.02B | -246.20M | 1.05B | 593.80M | 628.85M | 342.42M |
| EBITDA | 531.91M | -471.12M | 625.09M | 349.95M | 478.76M | -61.67M | 373.53M | -11.40M | -5.20M | 169.43M | 308.15M | 128.55M | -88.17M | 204.34M | 466.83M | -961.91M | 129.98M | 337.35M | 71.55M | 251.55M | 488.91M | -555.02M | -996.49M | -225.26M | 1.07B | 616.38M | 649.64M | 366.66M |
| EBITDA Ratio | 306.00% | 102.69% | 97.82% | 96.75% | 97.57% | 119.50% | 97.55% | -10.74% | 16.09% | 611.40% | 1,119.34% | 515.44% | -442.18% | 1,052.76% | 2,380.57% | -3,608.06% | 404.67% | 1,286.12% | 298.50% | 1,033.48% | 2,363.03% | -2,668.37% | -4,124.54% | -860.76% | 4,318.41% | 2,375.26% | 2,518.96% | 1,319.40% |
| Operating Income | 552.92M | -471.12M | 625.09M | 349.95M | 478.76M | -61.67M | 373.53M | 18.91M | 16.32M | 19.12M | 18.66M | 17.55M | 13.26M | 13.54M | 15.43M | 17.03M | 25.73M | 19.69M | 18.29M | 19.01M | 15.61M | 16.74M | 21.09M | 20.94M | 19.14M | 22.58M | 20.79M | 24.24M |
| Operating Income Ratio | 318.09% | 102.69% | 97.82% | 96.75% | 97.57% | 119.50% | 97.55% | 17.80% | 16.09% | 69.00% | 67.77% | 70.36% | 66.50% | 69.76% | 78.68% | 63.88% | 80.11% | 75.07% | 76.30% | 78.10% | 75.45% | 80.48% | 87.29% | 80.02% | 77.12% | 87.01% | 80.61% | 87.23% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 98.69M | -4.72M | 0.00 | 0.00 | 0.00 | -50.72M | 95.40M | 225.70M | -489.47M | 52.12M | 158.83M | 26.63M | 116.27M | 236.65M | -285.88M | -508.79M | -123.10M | 526.35M | 296.90M | 314.42M | 171.21M |
| Income Before Tax | 552.92M | -471.12M | 625.09M | 349.95M | 478.76M | -61.67M | 373.53M | 117.60M | 11.59M | 188.55M | 326.81M | 146.10M | -37.46M | 108.94M | 241.13M | -472.44M | 77.85M | 178.52M | 44.92M | 135.28M | 252.26M | -269.14M | -487.70M | -102.16M | 545.49M | 319.48M | 335.21M | 195.45M |
| Income Before Tax Ratio | 318.09% | 102.69% | 97.82% | 96.75% | 97.57% | 119.50% | 97.55% | 110.74% | 11.43% | 680.40% | 1,187.11% | 585.80% | -187.86% | 561.26% | 1,229.63% | -1,772.09% | 242.37% | 680.59% | 187.40% | 555.79% | 1,219.24% | -1,293.94% | -2,018.63% | -390.37% | 2,197.78% | 1,231.14% | 1,299.77% | 703.31% |
| Income Tax Expense | 0.00 | 22.54M | 19.06M | 21.78M | 478.76M | -161.14K | 373.53M | 117.60M | 16.79M | 169.43M | 308.15M | 128.55M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 552.92M | -471.12M | 625.09M | 349.95M | 478.76M | -61.67M | 373.53M | 117.60M | 11.59M | 188.55M | 326.81M | 146.10M | -37.46M | 108.94M | 241.13M | -472.44M | 77.85M | 178.52M | 44.92M | 135.28M | 252.26M | -269.14M | -487.70M | -102.16M | 545.49M | 319.48M | 335.21M | 195.45M |
| Net Income Ratio | 318.09% | 102.69% | 97.82% | 96.75% | 97.57% | 119.50% | 97.55% | 110.74% | 11.43% | 680.40% | 1,187.11% | 585.80% | -187.86% | 561.26% | 1,229.63% | -1,772.09% | 242.37% | 680.59% | 187.40% | 555.79% | 1,219.24% | -1,293.94% | -2,018.63% | -390.37% | 2,197.78% | 1,231.14% | 1,299.77% | 703.31% |
| EPS | 4.46 | -3.99 | 5.59 | 3.21 | 4.40 | -0.67 | 3.77 | 1.00 | 0.12 | 1.96 | 3.47 | 1.57 | -0.41 | 1.23 | 2.76 | -5.40 | 0.89 | 2.06 | 0.52 | 1.57 | 2.97 | -3.18 | -5.72 | -1.24 | 6.75 | 4.24 | 4.73 | 2.80 |
| EPS Diluted | 4.46 | -3.99 | 5.59 | 3.21 | 4.40 | -0.67 | 3.77 | 99.44M | 0.12 | 1.96 | 3.47 | 1.57 | -0.41 | 1.23 | 2.76 | -5.40 | 0.89 | 2.06 | 0.52 | 1.57 | 2.97 | -3.18 | -5.72 | -1.24 | 6.75 | 4.24 | 4.73 | 2.80 |
| Weighted Avg Shares Out | 124.05M | 118.08M | 111.82M | 109.02M | 108.87M | 92.04M | 99.08M | 117.60M | 97.91M | 96.29M | 94.22M | 93.03M | 91.07M | 88.89M | 87.42M | 87.41M | 87.67M | 86.84M | 86.10M | 86.14M | 84.89M | 84.54M | 85.23M | 82.29M | 80.84M | 75.27M | 70.86M | 69.91M |
| Weighted Avg Shares Out (Dil) | 124.05M | 118.08M | 111.82M | 109.02M | 108.87M | 92.04M | 99.08M | 1.18 | 97.91M | 96.29M | 94.22M | 93.03M | 91.07M | 88.89M | 87.42M | 87.41M | 87.67M | 86.84M | 86.10M | 86.14M | 84.89M | 84.54M | 85.23M | 82.29M | 80.84M | 75.27M | 70.86M | 69.91M |
5 Best CEFs This Month For 9% Plus Yield (September 2024)
For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper drawdowns than the broader market....
Seeking +8% Yields In A Lower Rate Environment
Using diversified funds to gain wide exposure and strong income can be a winning income strategy. One of our picks gives exposure to REITs which are primed to strongly benefit from rate cuts. The other pick has over half a...
Using The ADX Indicator In Trading: Practical Gold Futures Example
In the trading world, having the right tools and knowing how to use them correctly can be the difference between success and failure. One such tool is the Average Directional Index (ADX), which is acknowledged as a fundamental indicator for...
ADX: 6% Yield That Works In Few Situations
The Adams Diversified Equity Fund has been operating since 1929, offering consistent distributions with a current yield of 6.28%. ADX has historically delivered returns in line with or exceeding the S&P 500, generating slight alpha over the broader market. The...
9 Closed-End Fund Buys In The Month Of August 2024
The broader equity market saw declines in early August but ended near all-time highs to finish off the month. I put some capital to work this month at the low, but not as much as I had planned initially, as...
Stress And Work Kills, Dividends Provide
Workplaces and stress related to them are a top 5 causes of death in the U.S.; dividends have caused zero fatalities. We look at how dividends can provide for you and your loved ones, without trading your health for wealth....
These Incredible 10% Dividends Make Money 95% Of The Time
When it comes to investing, there are two critical “bedrocks” we need to keep in mind. Everything else builds out from there.
This 1-Click Move Gets You 8% Dividends From Everyday Stocks
Just a week ago, I wrote to you about the dangers of investing in a tired investor go-to called the 60/40 portfolio.
Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097
Q32 Bio's Bempikibart and ADX-097 are in Phase 2 trials, targeting autoimmune and inflammatory diseases, with significant potential to address unmet medical needs. The company's unique approach of localized inhibition minimizes side effects and enhances efficacy, differentiating it in the...
5 Best CEFs This Month For Nearly 9% Yield (August 2024)
For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper draw-downs than the broader market....
Source: https://incomestatements.info
Category: Stock Reports